BAG family molecular chaperone regulator 1 (BAG1)

BAG family molecular chaperone regulator 1 (BAG1) is a multifunctional co-chaperone protein initially identified as a binding partner for Bcl-2, the canonical anti-apoptotic protein[1][2][3][4]. It functions as a nucleotide exchange factor (NEF) for Hsp70/Hsc70 chaperones, facilitating ADP release and client protein unloading, thereby influencing protein folding, cellular stress response, and quality control[1][4]. BAG1 links chaperone activity with the ubiquitin-proteasome pathway, coupling protein folding with degradation, and plays a role in cell survival by enhancing the anti-apoptotic effects of Bcl-2 and stabilizing other pro-survival proteins (such as BCL-XL and MCL1), often by protecting them from proteasomal degradation[1][2][3]. Through these mechanisms, BAG1 is implicated in the regulation of apoptosis, cell proliferation, proteasome-dependent protein degradation, and nuclear receptor signaling. Deregulated BAG1 expression is observed in several human cancers (e.g., acute myeloid leukemia, breast, colorectal, and melanoma), correlating with chemotherapy and radiotherapy resistance and poor prognosis[2][4]. Increased BAG1 also plays a pathogenic role in neurodegenerative and cardiovascular diseases by modulating protein quality control and stress responses[3][4]. While not currently a direct drug target of approved therapeutics, its functional importance in cancer cell survival and resistance has made it an experimental target and a candidate biomarker for diagnosis and prognosis[2][4]. For structured information, no drugs are directly approved targeting BAG1 as a primary molecular target; however, its modulation or downstream effects (such as with proteasome inhibitors and experimental molecules) are therapeutically relevant. Potential safety concerns mainly stem from BAG1’s central roles in protein homeostasis and cell survival, suggesting a delicate therapeutic window[1][2][4].

Other names

Bcl-2-associated athanogene 1HAPRAP46BCL2 associated athanogene 1Bcl-2 associating athanogene-1 proteinBcl-2-binding proteinglucocorticoid receptor-associated protein RAP46receptor-associated protein 46-KDBAG-1BCL2-associated athanogene

Modulation of apoptosis (primarily through interaction with Bcl-2 family proteins), Regulation of proteasome-mediated protein degradation, Influence on chaperone-mediated substrate folding/unloading, Regulation of nuclear hormone receptor activity